Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 321, Issue 1, 2007, Pages 187-194

  Bolognesi, Massimo ^a,c   Sacerdoti, David ^a   Piva, Anna ^a   Di Pascoli, Marco ^a   Zampieri, Francesca ^a   Quarta, Santina ^a   Motterlini, Roberto ^b   Angeli, Paolo ^a   Merkel, Carlo ^a   Gatta, Angelo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b NORTHWICK PARK INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CALCIUM ACTIVATED POTASSIUM CHANNEL; CARBON MONOXIDE; CARBON TETRACHLORIDE; GUANYLATE CYCLASE; HEME OXYGENASE; HEME OXYGENASE 1; HEME OXYGENASE INHIBITOR; PHENYLEPHRINE; PROTEIN SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; LIVER CIRRHOSIS; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; VASODILATATION; WESTERN BLOTTING;

ACETYLCHOLINE; ANIMALS; BLOOD PRESSURE; CARBON MONOXIDE; CARBON TETRACHLORIDE POISONING; ENDOTHELIUM, VASCULAR; GUANYLATE CYCLASE; HEART RATE; HEME OXYGENASE (DECYCLIZING); LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; LIVER CIRRHOSIS; MALE; MESENTERIC ARTERIES; MESOPORPHYRINS; ORGANOMETALLIC COMPOUNDS; PHENYLEPHRINE; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; SPLANCHNIC CIRCULATION; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 33947365454     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.116665     Document Type: Article

References (39)

1. + channels in vascular smooth muscle during hypertension. J Clin Investig 112:717-724.
2. Amberg GC and Santana LF (2003a) Downregulation of the BK channel β1 subunit in genetic hypertension. Circ Res 93:965-971.
3. Ca channels. Circulation 107:769-776.
4. Barkoudah E, Jaggar JH, and Leffler CW (2004) The permissive role of endothelial NO in CO-induced cerebrovascular dilation. Am J Physiol 287:H1459-H1465.
5. + channels in in vitro nitric oxidemediated aortic hyporeactivity to alpha-adrenergic vasoconstriction in rats with cirrhosis. J Hepatol 35:350-357.
6. Bolognesi M, Sacerdoti D, Di Pascoli M, Angeli P, Quarta S, Sticca A, Pontisso P, Merkel C, and Gatta A (2005) Haeme oxygenase mediates hyporeactivity to phenylephrine in the mesenteric vessels of cirrhotic rats with ascites. Gut 54:1630-1636.
7. + channel proteins in vascular smooth muscle from rats made hypertensive with N-omega-nitro-L-arginine. Am J Physiol 289:H1284-H1290.
8. Clapp LH and Jabr RI (2003) The BK channel: protective or detrimental in genetic hypertension? Circ Res 93:893-895.
9. Clark JE, Naughton P, Shurey S, Green CJ, Johnson TR, Mann BE, Foresti R, and Motterlini R (2003) Cardioprotective actions by a water-soluble carbon monoxidereleasing molecule. Circ Res 93:e2-e8.
10. Dubuis E, Gautier M, Melin A, Rebocho M, Girardin C, Bonnet P, and Vandier C (2002) Chronic carbon monoxide enhanced IbTx-sensitive currents in rat resistance pulmonary artery smooth muscle cells. Am J Physiol 283:L120-L129.
11. Dubuis E, Potier M, Wang R, and Vandier C (2005) Continuous inhalation of carbon monoxide attenuates hypoxic pulmonary hypertension development presumably through activation of BKCa channels. Cardiovasc Res 65:751-761.
12. Fernandez M, Lambrecht RW, and Bonkovsky HL (2001) Increased heme oxygenase activity in splanchnic organs from portal hypertensive rats: role in modulating mesenteric vascular reactivity. J Hepatol 34:812-817.
13. Foresti R, Hammad J, Clark JE, Johnson TR, Mann BE, Friebe A, Green CJ, and Motterlini R (2004) Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule. Br J Pharmacol 142:453-460.
14. Gonzales-Abraldes J, Garcia-Pagan JC, and Bosch J (2002) Nitric oxide and portal hypertension. Metab Brain Dis 17:311-324.
15. + channels. Circ Res 91:610-617.
16. + channels. Circ Res 97:805-812.
17. Jaggar JH, Porter VA, Lederer WJ, and Nelson MT (2000) Calcium sparks in smooth muscle. Am J Physiol 278:C235-C256.
18. Johnson FK, Durante W, Peyton KJ, and Johnson RA (2003a) Heme oxygenase inhibitor restores arteriolar nitric oxide function in Dahl rats. Hypertension 41:149-155.
19. Johnson FK and Johnson RA (2003b) Carbon monoxide promotes endotheliumdependent constriction of isolated gracilis muscle arterioles. Am J Physiol 285:R536-R541.
20. Kaide JI, Zhang F, Wei Y, Wang W, Gopal VR, Falck JR, Laniado-Schwartzman M, and Nasjletti A (2004) Vascular CO counterbalances the sensitizing influence of 20-HETE on agonist-induced vasoconstriction. Hypertension 44:1-7.
21. Kotlikoff M and Hall I (2003) Hypertension: β testing. J Clin Investig 112:654-656.
22. Kozma F, Johnson RA, Zhang F, Yu C, Tong X, and Nasjletti A (1999) Contribution of endogenous carbon monoxide to regulation of diameter in resistance vessels. Am J Physiol 276:R1087-R1094.
23. + channels in the cerebral microcirculation of genetically hypertensive rats: evidence for their protection against cerebral vasospasm. Circ Res 82:729-737.
24. + channels in aorta of hypertensive rats. Hypertension 30:1403-1409.
25. Motterlini R, Gonzales A, Foresti R, Clark JE, Green CJ, and Winslow RM (1998) Heme oxygenase-1-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo. Circ Res 83:568-577.
26. Mulvany MJ and Aalkiaer C (1990) Structure and function of small arteries. Physiol Rev 70:921-961.
27. Naik JS, O'Donaughy TL, and Walker BR (2003a) Endogenous carbon monoxide is an endothelial-derived vasodilator factor in the mesenteric circulation. Am J Physiol 284:H838-H845.
28. Naik JS and Walker BR (2003b) Heme oxygenase-mediated vasodilation involves vascular smooth muscle cell hyperpolarization. Am J Physiol 285:H220-H228.
29. Sacerdoti D, Bolognesi M, Di Pascoli M, Gatta A, McGiff JC, Laniado Schwartzman M, and Abraham NG (2006) The rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid (EET) is mediated by activating heme oxygenase (HO). Am J Physiol 291:1999-2002.
30. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, and Rodes J (1988) Peripheral arterial vasodilation hypothesis: a proposal fort he initiation of renal sodium and water retention in cirrhosis. Hepatology 8:1151-1157.
31. Sieber C, Lopez-Talavera JC, and Groszmann RJ (1993) Role of nitric oxide in the in vitro splanchnic hyporeactivity in ascitic cirrhotic rats. Gastroenterology 104:1750-1754.
32. Sun D, Kaley G, and Koller A (1994) Characteristics and origin of myogenic response in isolated gracilis muscle arterioles. Am J Physiol 266:H1177-H1183.
33. Tanaka Y, Koike K, Alioua A, Stefani E, and Toro L (2004) β1-subunit of maxiK channel in smooth muscle: a key molecule which tunes muscle mechanical activity. J Pharmacol Sci 94:339-347.
34. Villamor E, Perez-Vizcaino F, Cogolludo AL, Conde-Oviedo J, Zaragoza-Arnaez F, Lopez-Lopez JG, and Tamargo J (2000) Relaxant effects of carbon monoxide compared with nitric oxide in pulmonary and systemic vessels of newborn piglets. Pediatr Res 48:546-553.
35. Wiest R and Groszmann RJ (1999) Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance. Semin Liver Dis 19:411-426.
36. Wilkinson SP and Williams R (1980) Renin-angiotensin-aldosterone system in cirrhosis. Gut 21:545-554.
37. Ca channels by nitric oxide and carbon monoxide. J Clin Investig 110:691-700.
38. Wu L and Wang R (2005) Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev 57:585-630.
39. Zhang F, Kaide JI, Rodriguez-Mulero F, Abraham NG, and Nasjletti A (2001) Vasoregulatory function of heme-heme oxygenase-carbon monoxide system. Am J Hypertension 14:62S-67S.